XBiotech Inc.XBITNASDAQ
Loading
Operating Cash Flow Growth Recovery in ProgressRecovering
Percentile Rank46
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
-28.93%
↓ 10% vs avg
Percentile
P46
Within normal range
Streak
1 yr
Consecutive growthRecovering
Average
-26.28%
Historical baseline
PeriodValue
2025-28.93%
2024-65.36%
2023-26.32%
2022-121.35%
2021206.59%
2020-256.59%
2019-10.48%
201850.85%
201726.87%
2016-38.15%